β-1腎上腺素受體拮抗劑用於製備減少表皮生長因子受體抑制劑誘導的上皮細胞損傷以及抑制癌細胞的組合物之用途

Translated title of the contribution: USE OF β-1 ADRENERGIC RECEPTOR ANTAGONIST FOR PREPARING COMPOSITIONS FOR REDUCING EPITHELIAL CELL DAMAGE INDUCED BY EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS AND INHIBITING CANCER CELLS

Wen-Hung Chung (Inventor), Yu-Shien Ko (Inventor), Jong-Hwei Su Pang (Inventor), MEI-JUN CHEN (Inventor), CHUN-WEI LU (Inventor)

Research output: Patent

Abstract

The present invention relates to the use of beta-1 adrenergic receptor antagonist for preparing compositions for reducing or preventing damage to normal epithelial cells induced by epidermal growth factor receptor inhibitors(EGFRI) and inhibiting cancer cells, by administering a composition containing a β-1 adrenergic receptor antagonist to reduce damage to normal epithelial cells induced by the EGFRI, and the composition containing β-1 adrenergic receptor antagonist can be administered together with an epidermal growth factor receptor inhibitor to synergistically inhibit cancer cells.
Translated title of the contributionUSE OF β-1 ADRENERGIC RECEPTOR ANTAGONIST FOR PREPARING COMPOSITIONS FOR REDUCING EPITHELIAL CELL DAMAGE INDUCED BY EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS AND INHIBITING CANCER CELLS
Original languageChinese (Traditional)
Patent numberI776584
IPCA61K 31/517(2006.01); A61K 31/138(2006.01); A61K 31/5377(2006.01); A61P 1/00(2006.01); A61P 17/00(2006.01)
StatePublished - 01 09 2022

Bibliographical note

公開公告號: I776584
Announcement ID: I776584

Fingerprint

Dive into the research topics of 'USE OF β-1 ADRENERGIC RECEPTOR ANTAGONIST FOR PREPARING COMPOSITIONS FOR REDUCING EPITHELIAL CELL DAMAGE INDUCED BY EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS AND INHIBITING CANCER CELLS'. Together they form a unique fingerprint.
View full fingerprint

Cite this